Latest Breaking News On - Agios pharmaceuticals - Page 2 : comparemela.com

Agios Pharmaceuticals (NASDAQ:AGIO) Hits New 1-Year High at $39.70

Agios Pharmaceuticals, Inc. (NASDAQ:AGIO – Get Free Report) hit a new 52-week high on Tuesday . The stock traded as high as $39.70 and last traded at $38.91, with a volume of 573087 shares changing hands. The stock had previously closed at $31.50. Wall Street Analysts Forecast Growth A number of equities analysts have recently […]

The Massive Deal That Could Send This Biotech Into A Break Out

Why Is Agios Pharmaceuticals Stock Trading Higher On Tuesday? - Agios Pharmaceuticals (NASDAQ:AGIO)

Agios Pharmaceuticals sells its 15% royalty rights on U.S. net sales of Servier's vorasidenib to Royalty Pharma for $905 million upon FDA approval.

Agios Pharmaceuticals, Inc. Announces $905 Million Purchase Agreement for Vorasidenib Royalty

Agios Pharmaceuticals, Inc. announced that the company has agreed to sell its rights to its 15% royalty on potential U.S. net sales of Servier?s vorasidenib to Royalty Pharma. Under the terms of the.

Stocks making the biggest moves midday: GME, USM, NVDA, NCLH

These are the stocks posting the largest moves midday.